123 related articles for article (PubMed ID: 17540600)
1. An aberrant high prevalence of hepatitis B infection among Afghans residing in one of the Bushehr refugee camps (Dalaki camp) in the southwest of Iran.
Pourkarim MR; Zandi K; Davani NA; Pourkarim HR; Amini-Bavil-Olyaee S
Int J Infect Dis; 2008 Jan; 12(1):101-2. PubMed ID: 17540600
[No Abstract] [Full Text] [Related]
2. Prevalence of hepatitis B among Afghan refugees living in Balochistan, Pakistan.
Quddus A; Luby SP; Jamal Z; Jafar T
Int J Infect Dis; 2006 May; 10(3):242-7. PubMed ID: 16448838
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran.
Alizadeh AH; Ranjbar M; Ansari S; MirArab A; Alavian SM; Mohammad K; Adibi P; Sadri GH; Keramat F; Ardalan A; Arabi M; Gharekhani S; Ataei A; Amraei GR; Hosseinzadeh M; Hatami S; Zali M
East Mediterr Health J; 2006 Sep; 12(5):528-37. PubMed ID: 17333790
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of hepatitis B virus among Bhutanese refugees residing in Nepal.
Shah BK; Bhattacharya S; Parija SC
Kathmandu Univ Med J (KUMJ); 2005; 3(3):239-42. PubMed ID: 18650584
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B prevalence among workers in Turkey at low risk for hepatitis B exposure.
Güven R; Ozcebe H; Cakir B
East Mediterr Health J; 2006 Nov; 12(6):749-57. PubMed ID: 17333819
[No Abstract] [Full Text] [Related]
6. Serum level of anti-hepatitis B surface antigen 6-8 years after hepatitis B vaccination at birth.
Kazemi A; Koosha A; Rafizadeh B; Mousavinasab N; Mahram M
East Mediterr Health J; 2008; 14(4):960-5. PubMed ID: 19166180
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B in refugees, guessing the prevalence.
Debes JD
Hepatology; 2010 Aug; 52(2):802-3. PubMed ID: 20683977
[No Abstract] [Full Text] [Related]
8. High prevalence of HBV infection markers in refugees from eastern countries.
Skliros EA; Sotiropoulos A; Peppas T; Sofroniadou K; Lionis C
Ital J Gastroenterol Hepatol; 1999; 31(1):84-5. PubMed ID: 10091110
[No Abstract] [Full Text] [Related]
9. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran.
Roshandel G; Semnani S; Abdolahi N; Besharat S; Keshtkar AA; Joshaqani H; Moradi A; Kalavi K; Jabbari A; Kabir MJ; Hosseini SA; Sedaqat SM; Danesh A; Roshandel D; Hedayat-Mofidi SM
J Microbiol Immunol Infect; 2008 Jun; 41(3):227-30. PubMed ID: 18629418
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy).
Majori S; Baldo V; Tommasi I; Malizia M; Floreani A; Monteiro G; Ferrari A; Accordini A; Guzzo P; Baldovin T
J Travel Med; 2008; 15(5):323-7. PubMed ID: 19006505
[TBL] [Abstract][Full Text] [Related]
12. Summary report and recommendations of the Expert Working Groups for Strain and Laboratory Surveillance of Hepatitis B Virus and Hepatitis C Virus.
Can Commun Dis Rep; 1999 Oct; 25(20):169-73. PubMed ID: 10575786
[No Abstract] [Full Text] [Related]
13. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran.
Sharifi-Mood B; Eshghi P; Sanei-Moghaddam E; Hashemi M
Saudi Med J; 2007 Oct; 28(10):1516-9. PubMed ID: 17914511
[TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of hepatitis B virus in Iran.
Mohebbi SR; Amini-Bavil-Olyaee S; Zali N; Noorinayer B; Derakhshan F; Chiani M; Rostami Nejad M; Antikchi MH; Sabahi F; Zali MR
Clin Microbiol Infect; 2008 Sep; 14(9):858-66. PubMed ID: 18844687
[TBL] [Abstract][Full Text] [Related]
17. HBV and HCV infection in Japanese dental care workers.
Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of hepatitis B carrier state in Khorassan province of Iran.
Farhat A; Khademi G; Mazlouman SJ
Saudi Med J; 2003 May; 24(5):549-51. PubMed ID: 12847639
[No Abstract] [Full Text] [Related]
19. Hepatitis B core antigen and hepatitis B surface antigen in a patient with active hepatitis B and HIV.
Cardenas A
J Hepatol; 2005 Feb; 42(2):284. PubMed ID: 15664260
[No Abstract] [Full Text] [Related]
20. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination.
Salleras L; Domínguez A; Bruguera M; Plans P; Costa J; Cardeñosa N; Batalla J; Plasència A
Vaccine; 2007 Dec; 25(52):8726-31. PubMed ID: 18045753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
